Postoperative Hypofractionated Intensity-modulated Radiotherapy Endometrial Cancer

Clinical trial NCT05876130 · RECRUITING

Trial details

NCT number: NCT05876130
Sponsor: Samsung Medical Center
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Endometrial Cancer

Start date: 2022-11-01
Primary completion: 2031-12-31
Enrollment: 92

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.